Athira Pharma, Inc.
Industry: Life Sciences ・ $ATHA on Nasdaq
Insider Purchase
+$99,216
+110.66%
Shares
Shares Volume: 42,400 Shares
Average Share Price: $2.34
INSIDER
Romano Kelly A
(Director)
reported on Jun 25 2024
traded on Jun 21 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 80,715 |
| PURCHASES/SALES 1Y | 1 / 0 |
| P/S VALUE RATIO | n/a |
| AVERAGE PURCHASE VALUE | $99,216 |
| INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 1 / 0 |
| PURCHASES/SALES 1Y | 2 / 9 |
| P/S VALUE RATIO | 21.869 |
| AVERAGE PURCHASE VALUE | $767,345.91 |
| COMPANY PREVIOUS TRADES |